Essix Biosciences Profile
Key Indicators
- Authorised Capital ₹ 27.37 Cr
as on 15-06-2024
- Paid Up Capital ₹ 14.50 Cr
as on 15-06-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 Cr
as on 15-06-2024
- Satisfied Charges ₹ 1,638.83 Cr
as on 15-06-2024
- Revenue -16.10%
(FY 2023)
- Profit 133.64%
(FY 2023)
- Ebitda 7.72%
(FY 2023)
- Net Worth 0.36%
(FY 2023)
- Total Assets -6.20%
(FY 2023)
About Essix Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 27.37 Cr and a paid-up capital of Rs 14.50 Cr.
The company currently has active open charges totaling ₹2.20 Cr. The company has closed loans amounting to ₹1,638.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Essix Biosciences Limited India are Pankaj as COMPANY SECRETARY and Ajit Kumar as Cfo. Himanshu Jain, Rishav Mehta, Subhash Galhotra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999CH1993PLC033428
- Company No.
033428
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Sep 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Essix Biosciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj | Company Secretary | Current | |
Navrattan Munjal  | Managing Director | 24-Sep-1993 | Current |
| Ajit Kumar | CFO | 31-Mar-2015 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Himanshu Jain | Director | 27-Aug-2008 | Current |
| Rishav Mehta | Director | 23-Mar-2010 | Current |
| Subhash Galhotra | Director | 31-Mar-2015 | Current |
| Prabhat Khurana | Director | 21-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Essix Biosciences.
Essix Biosciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.1% decrease. The company also saw a substantial improvement in profitability, with a 133.64% increase in profit. The company's net worth moved up by a moderate rise of 0.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Essix Biosciences?
In 2023, Essix Biosciences had a promoter holding of 77.69% and a public holding of 22.31%. The company had 2 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ind Swift Laboratories LimitedActive 29 years 11 monthsHimanshu Jain, Rishav Mehta and 1 more are mutual person
- Mjm Remedies Private LimitedActive 2 years 6 months
Himanshu Jain and Navrattan Munjal are mutual person
- Fortune (India) Constructions LimitedActive 19 years 9 months
Himanshu Jain and Subhash Galhotra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Feb 2022 | ₹2.00 M | Open |
Others Creation Date: 21 Dec 2021 | ₹1.00 Cr | Open |
Others Creation Date: 21 Dec 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Essix Biosciences?
Essix Biosciences has a workforce of 80 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Essix Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essix Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
